With the likes of Pfizer and Moderna leading in the race to a coronavirus vaccine, AstraZeneca shares have dropped by 3% following the company’s announcement that its vaccine candidate has proven to be 70% effective. This figure is significantly lower than that of Pfizer and Moderna.
In its phase 3...
After a 17% surge on Tuesday that resulted in a two-month high, hydrogen vehicle manufacturer Nikola suffered a 15% decrease in stock prices as markets came to a close. The Phoenix-based firm enjoyed a significant rise over the past few weeks in line with the electric vehicle market.
Nikola’s late...
While U.S. crude supplies have experienced a steady decline in recent times, oil has managed to retain its eight-month market highs. While an Energy Information Administration report showed a 754,000 decline in crude barrels last week, oil futures rose by 1.8% on the New York Stock Exchange.
These enduring highs...
With Moderna’s coronavirus vaccine candidate achieving an effectiveness rate of over 94% during the latest clinical trials, the biotech company completed a deal with the European Commission for the supply of at least 80 million doses of its vaccine, with the volume potentially amounting to 160 million depending on...
With online spending on Black Friday rising by 21.6% to $9 billion this year, Cyber Monday has been projected to be the biggest online shopping day to date. With sales estimates being projected to be anywhere between $10.8 billion and $12.7 billion, the NYSE has seen some major movements...
Sun Life Financial Inc. has announced the retirement of Chief Executive Officer Dean Connor, confirming that the long-term leader will hand the reins over to existing Chief Financial Officer Kevin Strain in August of next year.
In addition to taking the role of CEO, the 54-year-old businessman will also assume...
The British pound sterling climbed by as much as 1.2% to $1.3384 as of Sunday morning, following talks between the United Kingdom and the European Union regarding a trade deal following Brexit.
During discussions, British Prime Minister Boris Johnson and European Commission President Ursula von der Leyen agreed that both...
Pharmaceutical company AstraZeneca Plc has decided to make a move to purchase rare-disease specialist Alexion Pharmaceuticals Inc. for a hefty price tag of $39 billion. According to AstraZeneca, this move will account for the majority of the company’s growth, particularly following its low-return attempt at developing a COVID-19 vaccine...
Turkish Health Minister Fahrettin Koca announced on Thursday that the Turkish government reached a deal with Pfizer and BioNTech to purchase 4.5 million doses of their joint-effort coronavirus vaccine.
This deal provides an opportunity for the Turkish government to purchase another 30 million doses later on should they decide to...
Pennsylvania-based Inovio Pharmaceuticals Inc experienced a rise in share price following the company’s latest breakthrough regarding the development of its COVID-19 vaccine candidate.
As phase 1 test data showed, Inovio’s vaccine candidate, known as INO-4800, has been shown to be immunogenic in all test subjects. There was also no trace...